nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new approach for treating pancreatic cancer
|
Walker, Michael A. |
|
2010 |
15 |
5-6 |
p. 250- 1 p. |
artikel |
2 |
A structural informatics approach to mine kinase knowledge bases
|
Brooijmans, Natasja |
|
2010 |
15 |
5-6 |
p. 203-209 7 p. |
artikel |
3 |
Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy
|
Dick, Lawrence R. |
|
2010 |
15 |
5-6 |
p. 243-249 7 p. |
artikel |
4 |
Contents
|
|
|
2010 |
15 |
5-6 |
p. iii- 1 p. |
artikel |
5 |
Contents
|
|
|
2010 |
15 |
5-6 |
p. i- 1 p. |
artikel |
6 |
Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications
|
Menjoge, Anupa R. |
|
2010 |
15 |
5-6 |
p. 171-185 15 p. |
artikel |
7 |
Disease models – one size does not fit all
|
Kemp, Kaare |
|
2010 |
15 |
5-6 |
p. 161-162 2 p. |
artikel |
8 |
Does R&D pay?
|
Cavalla, David |
|
2010 |
15 |
5-6 |
p. 230-234 5 p. |
artikel |
9 |
Homologous recombination in human iPS and ES cells for use in gene correction therapy
|
Nakayama, Manabu |
|
2010 |
15 |
5-6 |
p. 198-202 5 p. |
artikel |
10 |
IAP antagonists: promising candidates for cancer therapy
|
Mannhold, Raimund |
|
2010 |
15 |
5-6 |
p. 210-219 10 p. |
artikel |
11 |
Rationalizing the chemical space of protein–protein interaction inhibitors
|
Sperandio, Olivier |
|
2010 |
15 |
5-6 |
p. 220-229 10 p. |
artikel |
12 |
The future of non-human primate use in mAb development
|
Chapman, Kathryn L. |
|
2010 |
15 |
5-6 |
p. 235-242 8 p. |
artikel |
13 |
Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection
|
Tan, Jian J. |
|
2010 |
15 |
5-6 |
p. 186-197 12 p. |
artikel |
14 |
The strategy of enantiomer patents of drugs
|
Agranat, Israel |
|
2010 |
15 |
5-6 |
p. 163-170 8 p. |
artikel |